After obtaining the necessary opinions and completing the legal and technical review, the Commission for Protection of Competition has submitted to the Government of the Republic of Serbia four new regulations for adoption, addressing the exemption of agreements from prohibition:

- Proposal for a Regulation on Categories of Vertical Agreements Exempted from the Prohibition of Restrictive Agreements
- Proposal for a Regulation on Categories of Vertical Agreements in the Motor Vehicle Sector Exempted from the Prohibition of Restrictive Agreements
- Proposal for a Regulation on Categories of Technology Transfer Agreements Exempted from the Prohibition of Restrictive Agreements
- Proposal for a Regulation on Categories of Agreements in the Railway and Road Transport Sector Exempted from the Prohibition of Restrictive Agreements

The Commission for Protection of Competition will carry out a sectoral analysis of the state and conditions of competition in the pharmaceutical market for human medicine in the Republic of Serbia.

The analysis will focus on the market for pharmaceuticals used in human medicine, with particular emphasis on drugs included in the official list prescribed and dispensed at the expense of mandatory health insurance funds. Additionally, the study will address pricing mechanisms, market shares, competitive conditions, potential barriers to market entry, vertical relations between wholesalers and pharmacies, and other related aspects.

The main objective is to identify potential measures and activities that the Commission, through opinions and proposals/recommendations, will submit to the relevant authorities and market participants, with the aim of enhancing the competitive conditions in this market.

At present, questionnaires are being distributed to pharmacy establishments with multiple retail outlets to gather the data required for the analysis.

Sorry, this entry is only available in Srpski.